Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

BRIDGE: a multi-stakeholder workstream focused on assessing new clinical endpoints in ophthalmology clinical trials [Building Research Innovations and Developing Global Endpoints]

BRIDGE Study Group. Eye (Lond). 2025 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Healthcare Professionals received consulting fees from Pharmaceutical Industry and Biotech, involved and not involved in the BRIDGE Study Group; authors listed from Pharmaceutical Industry and Biotech do have a conflict of interest due to the nature of their employee status. SS is the Editor in Chief for EYE.

Figures

Fig. 1
Fig. 1. Clinical Trials in AMD and DR/DME by Geographical Region.
Source: Trialtrove® | Citeline 2024: Recently completed, on-going or planned registrational trials in age-related macular degeneration (AMD) (A) and diabetic retinopathy (DR)/diabetic macular oedema (DMO) (B) by geographical region (Accessed data AMD 2024-11-15 and DR/DME 2024-11-26; adapted to BRIDGE focus).
See this image and copyright information in PMC

References

    1. Trialtrove: the go-to resource for informing clinical trial strategy, design and execution. Citeline; 2024.
    1. He W, Goodkind D, Kowal PUS. Census bureau, international population reports, P95/16-1, an aging world: 2015. Washington, DC: U.S. Government Publishing Office; 2016.
    1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. - PubMed
    1. Sarda SP, Heyes A, Bektas M, Thakur T, Chao W, Intorcia M, et al. Humanistic and economic burden of geographic atrophy: a systematic literature review. Clin Ophthalmol. 2021;15:4629–44. - PMC - PubMed
    1. Pablo L, Garay-Aramburu G, García, Layana A, Fernandez A, Vázquez I, et al. Assessing the economic burden of vision loss and irreversible legal blindness in Spain (2021-2030): a societal perspective. Health Econ Rev. 2024;14:70. - PMC - PubMed